Match tier
Listed
Presence
Formerly Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-16
S
Soheila Korourian
High Impact
Professor
Formerly Arkansas Affiliated with UA Little Rock, University of Arkansas, UAMS through 2024; recent publications list University of Alaska Anchorage, Alaska Neurology Center.
Faculty Researcher
Pathology, College of Medicine
44 h-index
169 pubs
5,449 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Soheila Korourian, Professor in the Department of Pathology at the University of Arkansas for Medical Sciences, leads a research group focused on understanding the impact of diet on metabolic health and disease. Her work has investigated the effects of soy protein concentrate, with varying levels of isoflavones, on non-alcoholic fatty liver disease (NAFLD) in obese Zucker rats. Studies have examined how dietary soy protein can reverse obesity-induced liver steatosis and alter gut microbial composition, with findings suggesting these effects can occur independently of isoflavone levels.
Further research explores the relationship between obesity and liver steatosis, including the potential therapeutic effects of metformin treatment. Korourian's publications also touch upon the role of obesity in promoting oxidative stress and DNA damage in mammary tumors within rat models. Her scholarship metrics include an h-index of 44, with 169 total publications and 5,429 total citations. She is recognized as a high-impact researcher and has collaborated with researchers including Reza Hakkak, Elisabet Børsheim, Nathan C. Twaddle, and Michael Scott Robeson.
Metrics
- h-index: 44
- Publications: 169
- Citations: 5,449
Selected Publications
-
Dietary soy protein reverses obesity-induced liver steatosis and alters fecal microbial composition independent of isoflavone level (2024)
-
Entrustable professional activities for cytopathology fellowship (2024)
-
Soy Protein Concentrate With Low and High Isoflavones Can Reverse Non-alcoholic Fatty Liver Disease Caused by Obesity and Alter Gut Microbial Composition (2024)
-
Long-Term Feeding Soy Protein Concentrates Protect Against Hepatic Steatosis Independent of Isoflavone Levels (2023)
-
Diet Containing Soy Protein Concentrate With Low and High Isoflavones for 9 Weeks Protects Against Non-alcoholic Fatty Liver Steatosis Using Obese Zucker Rats (2022)
-
Abstract 740: Obesity promotes liver pro-oxidative and DNA damage in mammary tumor of Zucker rats (2022)
-
Effects of 8 Weeks Feeding Diet with Low and High Isoflavones Soy Protein Concentrate on Serum Isoflavones in Non-alcoholic Fatty Liver Disease (NAFLD) Rat Model (2022)
-
Diet Containing Soy Protein Concentrate with Low and High Isoflavones for 18 Weeks Protects Against Non-alcoholic Fatty Liver Diseases (2022)
-
Effects of Obesity and Low and High Isoflavones in Soy Protein Concentrate Diet on Liver Steatosis (2021)
-
Effects of obesity and 10 weeks metformin treatment on liver steatosis (2021)
-
Abstract 3460: Effects of feeding soy protein isolate diet on hepatic methylation and oxidative stress in DMBA-induced mammary tumor in obese rat model (2020)
-
Abstract 4642: Effects of soy protein diet on plasma isoflavones levels in obese DMBA-induced mammary tumor rat model (2020)
-
Effects of Obesity and Short-Term Metformin Treatment on Liver Steatosis in Female Zucker Rats (2020)
-
Comparison of liver gene expression by RNAseq and PCR analysis after 8 weeks of feeding soy protein isolate- or casein-based diets in an obese liver steatosis rat model (2019)
-
Effects of Diet Containing Soy Protein Isolate on Liver Metabolic Methylation Status Using Obese Zucker Rat Model (P08-033-19) (2019)
Collaboration Network
Top Collaborators
Reza Hakkak
Arkansas Children's Hospital
9 shared publications
In database
- Diet Containing Soy Protein Concentrate With Low and High Isoflavones for 9 Weeks Protects Against Non-alcoholic Fatty Liver Steatosis Using Obese Zucker Rats
- Effects of obesity and 10 weeks metformin treatment on liver steatosis
- Long-Term Feeding Soy Protein Concentrates Protect Against Hepatic Steatosis Independent of Isoflavone Levels
- Dietary soy protein reverses obesity-induced liver steatosis and alters fecal microbial composition independent of isoflavone level
- Effects of Obesity and Low and High Isoflavones in Soy Protein Concentrate Diet on Liver Steatosis
Showing 5 of 9 shared publications
Beverly J. Spray
Arkansas Children's Hospital (US)
7 shared publications
- Diet Containing Soy Protein Concentrate With Low and High Isoflavones for 9 Weeks Protects Against Non-alcoholic Fatty Liver Steatosis Using Obese Zucker Rats
- Effects of obesity and 10 weeks metformin treatment on liver steatosis
- Long-Term Feeding Soy Protein Concentrates Protect Against Hepatic Steatosis Independent of Isoflavone Levels
- Dietary soy protein reverses obesity-induced liver steatosis and alters fecal microbial composition independent of isoflavone level
- Diet Containing Soy Protein Concentrate with Low and High Isoflavones for 18 Weeks Protects Against Non-alcoholic Fatty Liver Diseases
Showing 5 of 7 shared publications
David M. Irby
3 shared publications
- Diet Containing Soy Protein Concentrate with Low and High Isoflavones for 18 Weeks Protects Against Non-alcoholic Fatty Liver Diseases
- Effects of 8 Weeks Feeding Diet with Low and High Isoflavones Soy Protein Concentrate on Serum Isoflavones in Non-alcoholic Fatty Liver Disease (NAFLD) Rat Model
- Soy Protein Concentrate With Low and High Isoflavones Can Reverse Non-alcoholic Fatty Liver Disease Caused by Obesity and Alter Gut Microbial Composition
Elisabet Børsheim
Arkansas Children's Hospital
3 shared publications
In database
- Diet Containing Soy Protein Concentrate With Low and High Isoflavones for 9 Weeks Protects Against Non-alcoholic Fatty Liver Steatosis Using Obese Zucker Rats
- Long-Term Feeding Soy Protein Concentrates Protect Against Hepatic Steatosis Independent of Isoflavone Levels
- Dietary soy protein reverses obesity-induced liver steatosis and alters fecal microbial composition independent of isoflavone level
Melisa Kozaczek
University of Arkansas for Medical Sciences
2 shared publications
In database
- Effects of obesity and 10 weeks metformin treatment on liver steatosis
- Effects of Obesity and Low and High Isoflavones in Soy Protein Concentrate Diet on Liver Steatosis
Nathan C. Twaddle
United States Food and Drug Administration
2 shared publications
In database
- Dietary soy protein reverses obesity-induced liver steatosis and alters fecal microbial composition independent of isoflavone level
- Effects of 8 Weeks Feeding Diet with Low and High Isoflavones Soy Protein Concentrate on Serum Isoflavones in Non-alcoholic Fatty Liver Disease (NAFLD) Rat Model
Michael S. Robeson
University of Arkansas for Medical Sciences
2 shared publications
In database
- Dietary soy protein reverses obesity-induced liver steatosis and alters fecal microbial composition independent of isoflavone level
- Soy Protein Concentrate With Low and High Isoflavones Can Reverse Non-alcoholic Fatty Liver Disease Caused by Obesity and Alter Gut Microbial Composition
Shannon Rose
University of Arkansas for Medical Sciences
1 shared publication
In database
- Effects of obesity and 10 weeks metformin treatment on liver steatosis
Beverly Spary
1 shared publication
- Effects of Obesity and Low and High Isoflavones in Soy Protein Concentrate Diet on Liver Steatosis
David Irby
1 shared publication
- Effects of Obesity and Low and High Isoflavones in Soy Protein Concentrate Diet on Liver Steatosis
Stepan Melnyk
1 shared publication
In database
- Abstract 740: Obesity promotes liver pro-oxidative and DNA damage in mammary tumor of Zucker rats
Wei Li
University of Arkansas for Medical Sciences (US)
1 shared publication
- Long-Term Feeding Soy Protein Concentrates Protect Against Hepatic Steatosis Independent of Isoflavone Levels
Christopher Randolph
1 shared publication
- Soy Protein Concentrate With Low and High Isoflavones Can Reverse Non-alcoholic Fatty Liver Disease Caused by Obesity and Alter Gut Microbial Composition
Susanne K. Jeffus
University of Arkansas for Medical Sciences
1 shared publication
In database
- Entrustable professional activities for cytopathology fellowship
Chien Chen
University of Arkansas for Medical Sciences
1 shared publication
In database
- Entrustable professional activities for cytopathology fellowship
Similar Researchers
Based on overlapping research topics
Brian D. Piccolo
University of Arkansas for Medical Sciences
Diet and metabolism studies
Liver Disease Diagnosis and Treatment
Gut microbiota and health
Nora Cowen
University of Arkansas at Fayetteville
Diet and metabolism studies
Gut microbiota and health
Health Sciences Research and Education
Alyson G. Myers
University of Arkansas at Fayetteville
Diet and metabolism studies
Gut microbiota and health
Animal nutrition and physiology
W. Bottje
University of Arkansas at Fayetteville
Diet and metabolism studies
Gut microbiota and health
Animal nutrition and physiology
Diyana Albataineh
University of Arkansas at Fayetteville
Diet and metabolism studies
Liver Disease Diagnosis and Treatment
Animal nutrition and physiology
James D. Sikes
University of Arkansas for Medical Sciences
Diet and metabolism studies
Gut microbiota and health
Animal nutrition and physiology